TG Therapeutics down on missing Q2 estimates

TG Therapeutics

01/08/2023 14:08

** TG Therapeutics Inc's shares  TGTX.O  fall 38.6% to $12.6
    ** Stock among top pct loser across U.S. stocks trading
premarket
    ** Company missed Q2 sales and profit estimates on
lower-than expected sales of MS drug Briumvi
    ** Sales of $16.07 mln misses estimates of $17.45 mln -
Refinitiv
    ** Co posts loss of $0.34/shr vs estimates of loss of
$0.25/shr
    ** Up to Monday's close, stock had risen ~75% YTD

 (Reporting by Khushi Mandowara in Bengaluru)
 ((Khushi.Mandowara@thomsonreuters.com;))